XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Granted and Outstanding

A summary of options granted and outstanding is presented below.

 

   2022   2021 
   Options   Weighted
Average
Exercise
Price
   Options   Weighted
Average
Exercise
Price
 
Outstanding at Beginning of year   1,137,479   $5.18    792,857   $3.64 
Granted   367,500    1.63    511,764    7.00 
Cancelled   (3,571)   (4.38)   (21,875)   (4.38)
Forfeited   (143,286)  $(3.77)   (145,157)  $(2.57)
                     
Outstanding at end of year   1,358,122   $4.37    1,137,479   $5.18 
                     
Exercisable at end of year   1,132,861   $4.59    825,847   $5.38 
Schedule of Information About Options Outstanding

The following table summarizes information about options outstanding at December 31, 2022:

 

Exercise
Prices
   Options
Outstanding
   Aggregate
Intrinsic Value
   Weighted Average
Remaining
Contractual Life
   Options
Exercisable
  

Aggregate

Intrinsic Value
on Exercisable
Shares

 
                      
$1.21    307,500         -    4.42    168,551   $        - 
$1.39    10,000    -    4.67    10,000   $- 
$1.75    68,571    -    .25    68,571   $- 
$2.80    141,429    -    .50    141,429   $- 
$4.25    50,000    -    4.50    37,500   $- 
$4.38    244,286    -    2.25    244,286   $- 
$7.00    536,336    -    3.00    462,524   $- 
Schedule of Fair Value of Stock Option Awards

The fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

 

    Year Ended
December 31, 2022
    Year Ended
December 31, 2021
 
Expected term (years)     2.50 to 3.00       2.50 to 3.25  
Expected volatility     100.81% to 110.74 %     97.26% to 116.06 %
Risk-free interest rate     2.90% to 3.47 %     0.18% - .81 %
Dividend rate     0 %     0 %